Viral Vector Development
All times below listed in ET
Co-chairs: Carol Miao, PhD, and Anna Maurer, PhD
Register for Viral Vector Development
8:00 – 8:20 a.m.
Overview of Viral Vector Platforms
Negin Martin, PhD, NIEHS
8:20 – 8:40 a.m.
Lentiviral Vector Design and Applications
Axel Schambach, PhD, Hannover Medical School
8:40 – 9:00 a.m.
Adenoviral Vector Design and Applications
Maria G. Castro, PhD, University of Michigan Medical School
9:00 – 9:20 a.m.
From the Lab to the Clinic: Designing Preclinical Programs to Assess Efficacy and Safety for Novel Viral Vectors
Eva Andres-Mateos, PhD, Atsena Therapeutics
9:20 – 9:40 a.m.
Panel Discussion
Break: 9:40 – 10:00 a.m.
10:00 – 10:20 a.m.
AAV Vector Development
Mark Kay, PhD, Stanford University
10:20 – 10:40 a.m.
AAV Capsid Engineering and Library Approaches
Ben Deverman, PhD, Broad Institute
10:40 – 11:00 a.m.
AAV Vector Production from Small to Large Scales
Nathalie Clement, PhD. Unicorn Consultations, LLC
11:00 – 11:20 a.m.
AAV Vectors:Transgene Design
Charles Venditti, MD, PhD, National Human Genome Research Institute
11:20 – 11:40 a.m.
AAV Vectors: Tropism
Weidong Xiao, PhD, Indiana University
11:40 a.m. – 12:00 p.m.
Panel Discussion